BiotechTube
Home/Aeovian Pharmaceuticals/Davis C. Ryman, MD, PhD
DC

Davis C. Ryman, MD, PhD

Chief Medical Officer

Aeovian Pharmaceuticals

Therapeutic Areas

Rare Genetic DiseasesNeurologyAge-related Diseases

Aeovian Pharmaceuticals Pipeline

DrugIndicationPhase
AV078Tuberous Sclerosis Complex (TSC) Refractory EpilepsyPhase 1

Leadership Team at Aeovian Pharmaceuticals

AJ
Allison J. Hulme, PhD
CEO & President
JK
John Kincaid
Chief Scientific Officer
MZ
Micah Zajic
Chief Financial Officer
View full Aeovian Pharmaceuticals profile